4/A
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-20-034324
Director sold 33,000 shares at an average $143.35 ($4,730,448)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4a.xml…